返回 Agenda
Session Chair(s)
Stacey Fung, PHARMD
Head, Global Medical Information
Gilead Sciences, United States
Learning Objective : To provide an overview of currently available digital communication tools Medical Communication departments can use. Secondly, identify trends through the evaluation of adoption rates, barriers to implementation, and success and/or failure amongst US Medical Communication Departments.
Speaker(s)
Assessing New and Emerging Roles of Medical Communication Professionals in Bio-Pharmaceutical Industry Settings: Evolution from Supporting to a Leading Role
Dannis Chang, PHARMD
Genentech, Inc., United States
Director, Hematology Medical Information Team Lead
New Communication Channels and Tools: An Overview and Trends in Adoption and Implementation
Renard DuBois, PHARMD, MSC
Medivation, United States
Senior Manager, Medical Affairs
Globalization Pilot-Transforming US Medical Information Services (MIS)
Joyce P. Fairclough, PHARMD
Sanofi, United States
Senior Manager, Medical Information Services
Enhanced Medical Information Website Increases Site Utilization
Steven Hays, PHARMD, MBA
Pfizer Inc., United States
Associate Director, Medical Information
In-house Conversion of Medical Information Services from an External Vendor: Implementation and Outcomes
Hadley Le, PHARMD
Gilead Sciences, Inc., United States
Associate Manager, Medical Information
Responding to Medical Information Inquiries More Efficiently: What’s Involved When the Process has Regulatory Implications?
Krupa Paranjpe
Pfizer Inc, United States
Associate Director, Medical Infomation